Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Shepherd

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2009
Activation of hemostasis and decline in cognitive function in older peopleDavid J Stott, Michele Robertson, Ann Rumley, et al.
The New England Journal of Medicine|November 11, 2008
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinPaul M Ridker, Eleanor Danielson, Francisco A H Fonseca, et al.
The New England Journal of Medicine|March 31, 2009
A randomized trial of rosuvastatin in the prevention of venous thromboembolismRobert J Glynn, Eleanor Danielson, Francisco A H Fonseca, et al.
Atherosclerosis|February 12, 2008
Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPEREliana Polisecki, Hind Muallem, Nobuyo Maeda, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 5, 2008
Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapyMarc S Sabatine, Lynn Ploughman, Katy L Simonsen, et al.
Atherosclerosis|February 12, 2008
Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly populationEliana Polisecki, Inga Peter, Michele Robertson, et al.
Journal of the American College of Cardiology|January 29, 2008
Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trialsOlga A Iakoubova, Carmen H Tong, Charles M Rowland, et al.
Endocrine Reviews|February 16, 2017
Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization ApproachPaul Welsh, Eliana Polisecki, Michele Robertson, et al.
The Journal of Clinical Endocrinology and Metabolism|November 13, 2009
Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approachPaul Welsh, Eliana Polisecki, Michele Robertson, et al.
Plos Medicine|June 26, 2009
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?Naveed Sattar, Heather M Murray, Paul Welsh, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2009
Activation of hemostasis and decline in cognitive function in older peopleDavid J Stott, Michele Robertson, Ann Rumley, et al.
The New England Journal of Medicine|November 11, 2008
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinPaul M Ridker, Eleanor Danielson, Francisco A H Fonseca, et al.
The New England Journal of Medicine|March 31, 2009
A randomized trial of rosuvastatin in the prevention of venous thromboembolismRobert J Glynn, Eleanor Danielson, Francisco A H Fonseca, et al.
Atherosclerosis|February 12, 2008
Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPEREliana Polisecki, Hind Muallem, Nobuyo Maeda, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 5, 2008
Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapyMarc S Sabatine, Lynn Ploughman, Katy L Simonsen, et al.
Atherosclerosis|February 12, 2008
Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly populationEliana Polisecki, Inga Peter, Michele Robertson, et al.
Journal of the American College of Cardiology|January 29, 2008
Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trialsOlga A Iakoubova, Carmen H Tong, Charles M Rowland, et al.
Endocrine Reviews|February 16, 2017
Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization ApproachPaul Welsh, Eliana Polisecki, Michele Robertson, et al.
The Journal of Clinical Endocrinology and Metabolism|November 13, 2009
Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approachPaul Welsh, Eliana Polisecki, Michele Robertson, et al.
Plos Medicine|June 26, 2009
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?Naveed Sattar, Heather M Murray, Paul Welsh, et al.
Pageof 11